Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmamar: Yondelis and beyond

This article was originally published in Scrip

Executive Summary

The Spanish biotech company Pharmamar, has its sights set on expansion and has opened its first operations outside its home market in Italy. The firm's managing director, Luis Mora, spoke to Scrip about why Italy was a first good bet and what it plans to do beyond Yondelis (trabectedin), the only product it has so far brought to the market.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC018748

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel